Related Experiment Video
Updated: May 2, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Trust in the provider and glaucoma-related blindness
Kelly W Muir1, Brian Alder2, Anitra Thomas3
1Department of Ophthalmology, Duke Univeristy Medical Center, 2351 Erwin Road, P.O. Box 3802, Durham, NC 27710, USA ; Durham VA Medical Center, 508 Fulton Street, Durham, NC 27705, USA.
Abstract:
Purpose. We hypothesized that lower trust in the physician is associated with worse visual outcomes in glaucoma. Methods. Subjects completed the Trust in Provider Scale (TPS) and performed visual field tests at least two years apart. The primary outcome was glaucoma-related blindness. Results. Subjects with glaucoma-related blindness scored lower on the TPS (74.9 ± 7.4, n = 21) than subjects without blindness (78.8 ± 6.9, n = 39; P = 0.04). In white subjects, TPS scores were similar for blind (77.1 ± 7.7, n = 12) versus not blind subjects (76.4 ± 6.7, n = 10; P = 0.82). For nonwhite subjects, TPS scores were lower for blind (72.0 + 6.2, n = 9) versus not blind subjects (79.6 ± 6.9, n = 29; P = 0.005). In multiple regression models, the interaction between race and trust was significant (P = 0.007), indicating that the increase in odds for blindness with each unit decrease in TPS score was different for white versus nonwhite subjects. Discussion. Glaucoma patients' trust in the physician is associated with glaucoma-related blindness in this study. The association between lower trust in the physician with blindness in patients of nonwhite race deserves further attention as we strive to reduce disparities in visual outcomes.
More Related Videos
10:10Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
08:55Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Published on: April 24, 2020
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways
Blinding
Diabetic Retinopathy